CClinicalTrials.gg
CompletedNCT01034150Updated Dec 17, 2009

Effects of Home-based Neurostimulation Associated With Motor Training in Chronic Stroke Patients

A Phase 1/2 interventional study of Relief band (Somatosensory stimulation) and Placebo stimulation in Stroke, sponsored by University of Sao Paulo General Hospital. Completed at 1 site in Brazil. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2009-12-17.

Sponsored by University of Sao Paulo General Hospital · Phase 1/2, Interventional, and Treatment

Phase
Phase 1/2
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Objective: To investigate effects of home-based somatosensory stimulation associated with motor training on improvement in performance of the paretic upper extremity in patients in the chronic phase after stroke.

Read the detailed description

Design: Double-blind, randomized, controlled clinical trial. Setting: Home-based rehabilitation. Subjects: Patients in the chronic phase (> 6 months) after stroke. Interventions: Patients will be randomized to an active and a control group. In both groups, treatments will be performed at home, daily, over four weeks. Patients in the active group will be instructed to use a device that provides somatosensory stimulation in the form of electrical stimulation of the median nerve for two hours. Patients in the control group will also be instructed to use the device for two hours, and sham stimulation will be administered. In both groups, patients will be instructed to train activities with the paretic hand immediately after nerve stimulation.

Main measures: The primary outcome will be improvement in performance of the paretic hand evaluated by the Jebsen-Taylor test at end of treatment and four months after end of treatment, compared to baseline. Secondary outcomes were: 1) Compliance with the interventions, assessed through a daily written log, and oral reports of the patients; 2) safety profile of the interventions.

02

Conditions studied

  • Stroke

Browse trials for

03

In context

Stroke

7,283 studies on the registry are indexed under Stroke; 2,013 are open to participants now.

This study's enrollment of 20 is below the median of 50 across 5,366 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Sao Paulo General Hospital is the lead sponsor of 595 studies on the registry; 98 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age 18-80 years;
  • single ischemic or hemorrhagic stroke in a cerebral hemisphere, documented by computed tomography (CT) or magnetic resonance imaging (MRI);
  • stroke onset at least six months before;
  • hand paresis with preserved ability to perform all tasks of the Jebsen-Taylor Test (JTT).

Exclusion criteria

Exclusion Criteria:

  • previous strokes;
  • epilepsy and other neurological conditions;
  • proprioceptive or tactile anesthesia;
  • shoulder or hand pain;
  • severe joint deformity;
  • severe chronic disease;
  • inability to give provide informed consent due to severe aphasia or cognitive impairment;
  • left handedness before the stroke.
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    Somatosensory stimulation

    Active group

    Device: Relief band (Somatosensory stimulation)

  • Placebo comparator
    Control group

    Placebo stimulation

    Device: Placebo stimulation

Interventions

  • DeviceRelief band (Somatosensory stimulation)

    Electrical median nerve stimulation

    Also known as: Relief band

  • DevicePlacebo stimulation

    Placebo stimulation

    Also known as: no stimulation

06

What researchers measure

Primary outcomes

  1. the improvement in upper extremity performance assessed using Jebsen-Taylor test

    Time frame: Treatment lasted four weeks. Measures were performed before the treatment, immediately after the treatment and four months after the end of the treatment

Secondary outcomes

  1. Compliance with the interventions, assessed through a daily written log, and oral reports of the patients

    Time frame: immediately after the treatment

  2. Adverse events

    Time frame: at end of treatment

07

Study locations

1 site
  • University of São Paulo/General Hospital
    São Paulo, SP 55, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01034150
Lead sponsor
University of Sao Paulo General Hospital
Collaborators
Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico
First posted
Dec 17, 2009
Start date
Dec 2007
Primary completion
Sep 2009
Completion
Nov 2009
Last update
Dec 17, 2009

Study contacts

Adriana Conforto, MD PhD
principal investigator · Hospital das Clínicas/FMUSP

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion